Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model
A Nieto, G Domínguez-Bernal, JA Orden… - Veterinary …, 2011 - Springer
Several animal models have been established to study visceral leishmaniosis (VL), a
worldwide vector-borne disease affecting humans and domestic animals that constitutes a …
worldwide vector-borne disease affecting humans and domestic animals that constitutes a …
In Vitro and In Vivo Effectiveness of Carvacrol, Thymol and Linalool against Leishmania infantum
MR Youssefi, E Moghaddas, MA Tabari… - Molecules, 2019 - mdpi.com
Background: One of the most important causative agents of visceral leishmaniasis (VL) is
Leishmania infantum, which is mainly spread by Phlebotomus and Lutzomyia sandflies in …
Leishmania infantum, which is mainly spread by Phlebotomus and Lutzomyia sandflies in …
Hamster, a close model for visceral leishmaniasis: Opportunities and challenges
Aim Visceral leishmaniasis (VL) caused by parasites belonging to genus Leishmania (L.) is
classified as a category I disease by the TDR/WHO. The understanding of the pathogenesis …
classified as a category I disease by the TDR/WHO. The understanding of the pathogenesis …
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice
DP Lage, VT Martins, DL Vale, CS Freitas, BL Pimenta… - Acta Tropica, 2023 - Elsevier
Abstract Treatment of visceral leishmaniasis (VL) is compromised by drug toxicity, high cost
and/or the emergence of resistant strains. Though canine vaccines are available, there are …
and/or the emergence of resistant strains. Though canine vaccines are available, there are …
Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of …
ND Moreira, J Vitoriano-Souza, BM Roatt, PMA Vieira… - Parasites & …, 2016 - Springer
Background Leishmaniasis remains among the most important parasitic diseases in the
developing world and visceral leishmaniasis (VL) is the most fatal. The hamster …
developing world and visceral leishmaniasis (VL) is the most fatal. The hamster …
Causative Agents of American Tegumentary Leishmaniasis Are Able to Infect 3T3-L1 Adipocytes In Vitro
B Mendes, K Minori, SR Consonni… - Frontiers in Cellular …, 2022 - frontiersin.org
Although macrophages have long been considered key players in the course of Leishmania
infections, other non-professional phagocytes have lately been shown to maintain low levels …
infections, other non-professional phagocytes have lately been shown to maintain low levels …
Nanostructured lipid carriers as robust systems for lupeol delivery in the treatment of experimental visceral leishmaniasis
JA Jesus, TNF da Silva, IMO Sousa, AF Ferreira… - Pharmaceuticals, 2023 - mdpi.com
Leishmaniasis is a neglected tropical disease that affects millions of people around the
world. Available therapy causes severe side effects, has unacceptable prices for some …
world. Available therapy causes severe side effects, has unacceptable prices for some …
In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative
L de Almeida, TG Passalacqua, LA Dutra… - Biomedicine & …, 2017 - Elsevier
N-oxide derivatives compounds such as furoxan and benzofuroxan are promising scaffolds
for designing of new antileishmanial drugs. A series of furoxan (1, 2, 5-oxadiazole 2-N …
for designing of new antileishmanial drugs. A series of furoxan (1, 2, 5-oxadiazole 2-N …
[HTML][HTML] Lipophosphoglycan-3 recombinant protein vaccine controls hepatic parasitism and prevents tissue damage in mice infected by Leishmania infantum chagasi
DSS Bastos, BM Miranda, TVF Martins… - Biomedicine & …, 2020 - Elsevier
Aims In this work, we aimed to evaluate the effects of the Leishmania infantum chagasi
infection on the liver of vaccinated mice, considering parameters of tissue damage and the …
infection on the liver of vaccinated mice, considering parameters of tissue damage and the …